Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Recombinant fragment corresponding to a region within amino acids 20 and 249 of Human alanyl-tRNA synthetase|
|Purification||Antigen affinity chromatography|
|Storage buffer||PBS, pH 7, with 20% glycerol|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:100-1:1000|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA5-29496 targets alanyl-tRNA synthetase in IHC (P) and WB applications and shows reactivity with Human samples.
The PA5-29496 immunogen is recombinant fragment corresponding to a region within amino acids 20 and 249 of Human alanyl-tRNA synthetase.
The human alanyl-tRNA synthetase (AARS) belongs to a family of tRNA synthases, of the class II enzymes. Class II tRNA synthases evolved early in evolution and are highly conserved. This is reflected by the fact that 498 of the 968-residue polypeptide human AARS shares 41% identity witht the E.coli protein. tRNA synthases are the enzymes that interpret the RNA code and attach specific aminoacids to the tRNAs that contain the cognate trinucleotide anticodons. They consist of a catalytic domain which interacts with the amino acid acceptor-T psi C helix of the tRNA, and a second domain which interacts with the rest of the tRNA structure.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
AARS; alanine tRNA ligase 1; alanine tRNA ligase 1, cytoplasmic; alanine--tRNA ligase; alanyl-tRNA synthetase; alanyl-tRNA synthetase, cytoplasmic; alaRS; CMT2N; cytoplasmic; renal carcinoma antigen NY-REN-42
AARS; CMT2N; EIEE29